- Report
- April 2018
Global
From €964EUR$1,000USD£825GBP
- Report
- September 2019
Global
From €5177EUR$5,370USD£4,428GBP
- Report
- January 2022
- 137 Pages
Global
From €4338EUR$4,500USD£3,710GBP
Potiga is a medication used to treat seizures associated with epilepsy. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to reduce the frequency and severity of seizures. Potiga works by blocking sodium channels in the brain, which helps to reduce the electrical activity that causes seizures. It is usually taken in combination with other antiepileptic drugs.
Potiga is approved by the US Food and Drug Administration (FDA) for use in adults and children over the age of four. It is available in tablet form and is taken once daily. Common side effects include dizziness, drowsiness, and nausea.
The Potiga market is composed of a variety of companies that produce and distribute the drug. These include GlaxoSmithKline, Eisai, and Sun Pharmaceuticals. Other companies involved in the market include Mylan, Teva Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more